Evidence map›Paper›PMID 21239119›Full record

Trial reportAddictive behaviors2011

Differences in smoking expectancies in smokers with and without a history of major depression.

Andrea H Weinberger, Tony P George, Sherry A McKee

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Addictive behaviors, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2014
    Pooled it
  3. Smoking cessation interventions for smokers with current or past depression.The Cochrane database of systematic reviews · 2013
    Pooled it
  4. Trial
  5. Identifying mechanisms that link pain to smoking relapse during a quit attempt.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2021
    Trial
  6. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Trial
  7. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.Redox report : communications in free radical research · 2015
    Trial
  8. Trial
  9. Review
  10. Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Two decades of smoking cessation treatment research on smokers with depression: 1990-2010.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Andrea H WeinbergerDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA. andrea.weinberger@yale.edu
Tony P George
Sherry A McKee
Yale University · USUniversity of Toronto · CA

Funding

SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Tobacco Dependence &Risk Factors for Treatment FailureP50AA015632 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2008
$9.2M
Selegiline for Smoking CessationR01DA015757 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2004 to 2007
$1.4M
CIHRNIAAA NIH HHS P50 AA015632NIAAA NIH HHS P50-AA015632NIDA NIH HHS K12 DA000167NIDA NIH HHS K12-DA000167NIDA NIH HHS R01 DA015757NIDA NIH HHS R01-DA015757
6 · The paper itself

Abstract

Adults with depression evidence higher rates of smoking and lower quit rates than adults without depression. Little is known about the relationship between depression and smoking beliefs which are associated with both smoking and smoking cessation behavior. The primary aim of this study was to examine whether adult smokers with and without a history of major depressive disorder (MDD) differ in their endorsement of smoking expectancies. The secondary aim of the study was to examine whether there were interactions of depression and gender on the endorsement of expectancies. Adult cigarette smokers participating in a clinical trial of Selegiline hydrochloride for smoking cessation were classified as having a history of depression (MDD+, n=26) or no history of depression (MDD-, n=75). History of depression and smoking expectancies were assessed prior to randomization into the clinical trial. There was a main effect of depression on 7 out of 10 of the assessed beliefs. MDD+ smokers, compared to MDD- smokers, more strongly endorsed beliefs that smoking reduces negative affect, boredom, and cravings; smoking increases stimulation and social facilitation; smoking helps to manage cravings and weight; and that the taste is enjoyable. The main effect of gender and the interactive effect of depression and gender were not significant. Incorporating expectancies into cognitive-behavioral treatments for smoking cessation may be useful for smokers with a history of depression.

Indexed as

AdolescentAdultAgedDouble-Blind MethodFemaleHumansMajor Depressive DisorderMaleMiddle AgedMonoamine Oxidase InhibitorsPsychiatric Status Rating ScalesSelegilineSex FactorsSmokingSmoking CessationSurveys and QuestionnairesMonoamine Oxidase InhibitorsSelegiline

Identifiers

PMID21239119
PMCPMC3052745
OpenAlexW2086437016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.